Mackay, Alan <br/><br/>
Molecular, Pathological, Radiological, and Immune Profiling of Non-brainstem Pediatric High-Grade Glioma from the HERBY Phase II Randomized Trial.  [electronic resource] 

 -  Cancer cell  05 2018 
 - 829-842.e5 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1878-3686 
<br/><br/><label>Standard No.: </label>10.1016/j.ccell.2018.04.004  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Bevacizumab--therapeutic use<br/>CD8-Positive T-Lymphocytes<br/>Chemoradiotherapy--methods<br/>Child<br/>Child, Preschool<br/>DNA Polymerase III--genetics<br/>Female<br/>Glioma--genetics<br/>Humans<br/>Male<br/>Mutation<br/>Neoplasm Grading<br/>Neurofibromin 1--genetics<br/>Proto-Oncogene Proteins B-raf--genetics<br/>Survival Analysis<br/>Temozolomide--therapeutic use